Cough syrup deaths: Delhi govt bans sale, distribution of Coldrif

New Delhi: The Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared “not of standard quality”, an official order said.

According to the order issued on Friday, Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate Syrup), manufactured in May 2025 by Sresan Pharmaceutical Manufacturer, Tamil Nadu, was found to be adulterated with Diethylene Glycol (46.28 per cent w/v), a toxic chemical known to be harmful to human health.

Also Read

Cough syrup deaths: Court remands TN-based firm owner in 10-day police custody

All stakeholders are directed to immediately stop selling, purchasing, or distributing the said batch of the syrup. The general public has also been advised not to use the product, given its potential health risks, the order said.

The assistance of all stakeholders is sought for the strict implementation and wide dissemination of the public advisory, which has been issued in public interest, it said.

Get the latest updates in Hyderabad City News, Technology, Entertainment, Sports, Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS.